165 related articles for article (PubMed ID: 6181912)
1. Mechanism of action of human pancreatic and salivary alpha-amylase on alpha-4-nitrophenyl maltoheptaoside substrate.
Hägele EO; Schaich E; Rauscher E; Lehmann P; Bürk H; Wahlefeld AW
Clin Chem; 1982 Nov; 28(11):2201-5. PubMed ID: 6181912
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of human pancreatic and salivary alpha-amylase on 4,6-ethylidene-alpha-4-nitrophenyl-maltoheptaoside substrate.
Hägele EO; Kratzer M; Schaich E; Rauscher E
Clin Chem; 1989 Jan; 35(1):188-9. PubMed ID: 2783397
[No Abstract] [Full Text] [Related]
3. Pancreatic and salivary amylase determination using a short-chain chromogenic substrate (alpha-4-nitrophenyl-maltoheptaoside) and an amylase inhibitor.
Soyama K; Ono E
Clin Chim Acta; 1983 Jun; 131(1-2):149-54. PubMed ID: 6192948
[TBL] [Abstract][Full Text] [Related]
4. 2-Chloro-4-nitrophenyl-beta-D-maltoheptaoside: a new substrate for the determination of alpha-amylase in serum and urine.
Henkel E; Morich S; Henkel R
J Clin Chem Clin Biochem; 1984 Jul; 22(7):489-95. PubMed ID: 6332876
[TBL] [Abstract][Full Text] [Related]
5. Action pattern of serum amylase using p-nitrophenyl-maltoheptaoside as substrate.
Masson P; Hultberg B
J Clin Chem Clin Biochem; 1984 Jun; 22(6):427-30. PubMed ID: 6207265
[TBL] [Abstract][Full Text] [Related]
6. Action pattern of human pancreatic and salivary alpha-amylase on 1,4-alpha-D-nitrophenylmaltooligosaccharides. 1,4-alpha-D-nitrophenylmaltooligosaccharides as substrates of alpha-amylse, I.
Wallenfels K; Laule G; Meltzer B
J Clin Chem Clin Biochem; 1982 Aug; 20(8):581-6. PubMed ID: 6183388
[TBL] [Abstract][Full Text] [Related]
7. The determination of alpha-amylase with 2-chloro-4-nitrophenyl-beta-D-maltoheptaoside as substrate: comparison with other methods.
Hafkenscheid JC; Hessels M
J Clin Chem Clin Biochem; 1985 Sep; 23(9):529-33. PubMed ID: 3877781
[TBL] [Abstract][Full Text] [Related]
8. Determination of alpha-amylase using a new blocked substrate (3-ketobutylidene beta-2-chloro-4-nitrophenyl-maltopentaoside).
Teshima S; Hayashi Y; Emi S; Ishimaru K
Clin Chim Acta; 1991 May; 199(1):23-31. PubMed ID: 1934499
[TBL] [Abstract][Full Text] [Related]
9. Optimized conditions for determining activity concentration of alpha-amylase in serum, with 1,4-alpha-D-4-nitrophenylmaltoheptaoside as substrate.
Rauscher E; Neumann U; Schaich E; von Bülow S; Wahlefeld AW
Clin Chem; 1985 Jan; 31(1):14-9. PubMed ID: 3871178
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody that specifically inhibits human salivary alpha-amylase.
Gerber M; Naujoks K; Lenz H; Wulff K
Clin Chem; 1987 Jul; 33(7):1158-62. PubMed ID: 3496177
[TBL] [Abstract][Full Text] [Related]
11. Measurement of pancreatic and salivary alpha-amylase in serum: comparison of methods with five different substrates.
Hafkenscheid JC; Hessels M
Enzyme; 1985; 33(3):128-33. PubMed ID: 3876927
[TBL] [Abstract][Full Text] [Related]
12. Differential rate assay of human pancreatic and salivary alpha-amylases in serum using two coupled enzymes.
Omichi K; Ikenaka T
J Biochem; 1986 Nov; 100(5):1353-8. PubMed ID: 3546280
[TBL] [Abstract][Full Text] [Related]
13. Alpha-amylase determination with the Reflotron reagent carrier system: use of whole blood, plasma, and serum, and effect of isoenzymes.
Bais R; Badenoch J; Bayer PM; Foo Y; Keller H; Koller PU; Leinberger R; Weidemann G; Rosalki SB
Clin Chem; 1989 Feb; 35(2):317-20. PubMed ID: 2783664
[TBL] [Abstract][Full Text] [Related]
14. Alpha-amylase assay with use of a benzyl derivative of p-nitrophenyl alpha-maltopentaoside, BG5P.
Satomura S; Sakata Y; Omichi K; Ikenaka T
Clin Chim Acta; 1988 Jun; 174(3):315-23. PubMed ID: 3134147
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of human non-salivary, non-pancreatic alpha-amylase from salivary and pancreatic alpha-amylases by use of FG5P.
Omichi K; Shiosaki K; Matsubara K; Ikenaka T
J Biochem; 1990 Apr; 107(4):546-9. PubMed ID: 2358428
[TBL] [Abstract][Full Text] [Related]
16. Rapid determination of alpha-amylase activity by use of a new chromogenic substrate.
Dupuy G; Hilaire G; Aubry C
Clin Chem; 1987 Apr; 33(4):524-8. PubMed ID: 3103953
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a new alpha-amylase assay using 4.6-ethylidene-(G7)-1-4-nitrophenyl-(G1)-alpha-D-maltoheptaoside as substrate.
Kruse-Jarres JD; Kaiser C; Hafkenscheid JC; Hohenwallner W; Stein W; Bohner J; Klein G; Poppe W; Rauscher E
J Clin Chem Clin Biochem; 1989 Feb; 27(2):103-13. PubMed ID: 2787387
[TBL] [Abstract][Full Text] [Related]
18. Immunocatalytic assay of pancreatic alpha-amylase in serum and urine with a specific monoclonal antibody.
Svens E; Käpyaho K; Tanner P; Weber TH
Clin Chem; 1989 Apr; 35(4):662-4. PubMed ID: 2784725
[TBL] [Abstract][Full Text] [Related]
19. Direct spectrophotometric determination of alpha-amylase activity in salive, with p-nitrophenyl alpha-maltoside as substrate.
Gillard BK; Marksman HC; Feig SA
Clin Chem; 1977 Dec; 23(12):2279-82. PubMed ID: 303555
[TBL] [Abstract][Full Text] [Related]
20. Automated measurement of amylase isoenzymes by a double kinetic assay with "blocked" beta-2-chloro-4-nitrophenyl maltopentaoside as substrate and with wheat germ inhibitor.
Abe A; Nishimura T; Noma A; Hamano K
Clin Chem; 1991 Aug; 37(8):1345-9. PubMed ID: 1714360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
